159 related articles for article (PubMed ID: 8462246)
1. Oncogenes and growth factors in human lung cancer.
Kern JA; Filderman AE
Clin Chest Med; 1993 Mar; 14(1):31-41. PubMed ID: 8462246
[TBL] [Abstract][Full Text] [Related]
2. [Recent advances in gene change of pancreatic cancer].
Wang YY; Cui QC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):79-82. PubMed ID: 15052782
[TBL] [Abstract][Full Text] [Related]
3. The biology of lung cancer including potential clinical applications.
Zöchbauer-Müller S; Minna JD
Chest Surg Clin N Am; 2000 Nov; 10(4):691-708. PubMed ID: 11091920
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetics of small cell lung carcinoma.
Wistuba II; Gazdar AF; Minna JD
Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
[TBL] [Abstract][Full Text] [Related]
5. [2000 Standards, Options and Recommendations for prognostic value of oncogenes and tumor suppressor genes in non small cell lung cancer].
Bréchot JM; Molina T; Theobald S; Depierre A; Lagrange JL; Astoul P; Baldeyrou P; Bardet E; Bazelly B; Breton JL; Douillard JY; Grivaux M; Jacoulet P; Khalil A; Lemarié E; Martinet Y; Massard G; Milleron B; Moro-Sibilot D; Paesmans M; Pujol JL; Quoix AE; Ranfaing E; Rivière A; Sancho-Garnier H; Souquet PJ; Spaeth D; Stcebner-Delbarre A;
Bull Cancer; 2002 Oct; 89(10):857-67. PubMed ID: 12441277
[TBL] [Abstract][Full Text] [Related]
6. Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer.
Schneider PM; Praeuer HW; Stoeltzing O; Boehm J; Manning J; Metzger R; Fink U; Wegerer S; Hoelscher AH; Roth JA
Br J Cancer; 2000 Aug; 83(4):473-9. PubMed ID: 10945494
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine tumors of the lung. Pathology and molecular biology.
Vuitch F; Sekido Y; Fong K; Mackay B; Minna JD; Gazdar AF
Chest Surg Clin N Am; 1997 Feb; 7(1):21-47. PubMed ID: 9001754
[TBL] [Abstract][Full Text] [Related]
8. Molecular biologic features of non-small cell lung cancer. Clinical implications.
Rusch VW; Dmitrovsky E
Chest Surg Clin N Am; 1995 Feb; 5(1):39-55. PubMed ID: 7743147
[TBL] [Abstract][Full Text] [Related]
9. [Genetic abnormalities in lung cancer and their prognostic implications].
Mitsudomi T; Takahashi T
Gan To Kagaku Ryoho; 1996 Jul; 23(8):990-6. PubMed ID: 8687234
[TBL] [Abstract][Full Text] [Related]
10. [Study of prognostic factors in patients with stage I non-small cell lung cancer].
Jiang ZQ; Jiang GL; Shi DR; Zhang RX; Fu XL; Qian H
Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):364-8. PubMed ID: 15312349
[TBL] [Abstract][Full Text] [Related]
11. Molecular and cellular biology of small cell lung cancer.
Sattler M; Salgia R
Semin Oncol; 2003 Feb; 30(1):57-71. PubMed ID: 12635090
[TBL] [Abstract][Full Text] [Related]
12. [Application of molecular diagnosis to human lung cancer].
Isobe T
Rinsho Byori; 1995 Aug; 43(8):792-8. PubMed ID: 7474438
[TBL] [Abstract][Full Text] [Related]
13. Prediction of recurrence for advanced breast cancer. Traditional and contemporary pathologic and molecular markers.
Masood S
Surg Oncol Clin N Am; 1995 Oct; 4(4):601-32. PubMed ID: 8535901
[TBL] [Abstract][Full Text] [Related]
14. Oncogenes, tumour suppressor genes and growth factors in breast cancer: novel targets for diagnosis, prognosis and therapy.
Callahan R; Salomon DS
Cancer Surv; 1993; 18():35-56. PubMed ID: 8012999
[TBL] [Abstract][Full Text] [Related]
15. Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspective.
Sakorafas GH; Tsiotou AG; Tsiotos GG
Cancer Treat Rev; 2000 Feb; 26(1):29-52. PubMed ID: 10660490
[TBL] [Abstract][Full Text] [Related]
16. Clinical implication and prognostic significance of the tumor suppressor TSLC1 gene detected in adenocarcinoma of the lung.
Uchino K; Ito A; Wakayama T; Koma Y; Okada T; Ohbayashi C; Iseki S; Kitamura Y; Tsubota N; Okita Y; Okada M
Cancer; 2003 Sep; 98(5):1002-7. PubMed ID: 12942568
[TBL] [Abstract][Full Text] [Related]
17. c-Myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expression.
Barr LF; Campbell SE; Diette GB; Gabrielson EW; Kim S; Shim H; Dang CV
Cancer Res; 2000 Jan; 60(1):143-9. PubMed ID: 10646866
[TBL] [Abstract][Full Text] [Related]
18. [Genetic alteration in lung cancer].
Hashimoto T; Hayashi M; Tsuchiya E
Nihon Rinsho; 2002 May; 60 Suppl 5():78-82. PubMed ID: 12101778
[No Abstract] [Full Text] [Related]
19. Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer.
Kim JS; Kim JW; Han J; Shim YM; Park J; Kim DH
Cancer Res; 2006 Apr; 66(8):4049-54. PubMed ID: 16618724
[TBL] [Abstract][Full Text] [Related]
20. A novel molecular staging protocol for non-small cell lung cancer.
Miyake M; Adachi M; Huang C; Higashiyama M; Kodama K; Taki T
Oncogene; 1999 Apr; 18(14):2397-404. PubMed ID: 10327061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]